PMID- 33718099
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210316
IS  - 2223-4691 (Print)
IS  - 2223-4691 (Electronic)
IS  - 2223-4683 (Linking)
VI  - 10
IP  - 2
DP  - 2021 Feb
TI  - Giant bilateral primary scrotal lipoma along with lipomas in multiple sites of 
      the body: a case report and literature review.
PG  - 983-990
LID - 10.21037/tau-20-1073 [doi]
AB  - Mesenchymal neoplasms of the scrotum are extremely rare in the clinical 
      practices, in which lipoma is the most common benign neoplasm of them. Primary 
      scrotal lipoma refers to the lipoma originated from scrotal wall. We reported a 
      rare case of a 47-year-old man who suffered from bilateral giant primary scrotal 
      lipoma along with lipomas in multiple sites of the body. Scrotal ultrasound 
      indicated that huge hypoechogenic masses were observed in the bilateral scrotums. 
      Contrast-enhanced computed tomography (CT) indicated increased fat density in the 
      scrotal areas. Surgical resection was performed on both scrotal neoplasms. 
      Diagnosis of lipoma was confirmed by the pathological examination through the 
      morphological observation as well as the absence of murine double minute2 (MDM2) 
      gene amplification in the fluorescence in situ hybridization (FISH) test. After 
      five months of follow-up, the wound of the patient recovered well and no sign of 
      local recurrence was observed. Based on the literature review, very few cases of 
      primary scrotal lipoma were reported in the scientific literature up to date, and 
      this is the first report of bilateral primary scrotal lipoma along with multiple 
      lipomas of the body. We presented this case as a rare phenomenon. Although 
      primary scrotal lipoma is rare, clinicians should take it into account when 
      encountering similar scrotal lesions and know the methods for diagnosis and how 
      to make differential diagnosis with other diseases, which is associated with the 
      patient's treatment strategy and prognosis.
CI  - 2021 Translational Andrology and Urology. All rights reserved.
FAU - Zheng, Weitao
AU  - Zheng W
AD  - Department of Urology, Institute of Urology, West China Hospital, Sichuan 
      University, Chengdu, China.
FAU - Shi, Ming
AU  - Shi M
AD  - Department of Urology, Institute of Urology, West China Hospital, Sichuan 
      University, Chengdu, China.
FAU - Li, Tao
AU  - Li T
AD  - Department of Gynecology and Obstetrics, Development and Related Disease of Women 
      and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects 
      and Related Diseases of Women and Children, Ministry of Education, West China 
      Second Hospital, Sichuan University, Chengdu, China.
FAU - Xu, Hang
AU  - Xu H
AD  - Department of Urology, Institute of Urology, West China Hospital, Sichuan 
      University, Chengdu, China.
FAU - Chen, Zeyu
AU  - Chen Z
AD  - Department of Urology, Institute of Urology, West China Hospital, Sichuan 
      University, Chengdu, China.
FAU - Wang, Xingyuan
AU  - Wang X
AD  - Department of Urology, Institute of Urology, West China Hospital, Sichuan 
      University, Chengdu, China.
FAU - Bai, Shengjiang
AU  - Bai S
AD  - Department of Urology, Institute of Urology, West China Hospital, Sichuan 
      University, Chengdu, China.
FAU - Le, Weizhen
AU  - Le W
AD  - Department of Urology, Institute of Urology, West China Hospital, Sichuan 
      University, Chengdu, China.
FAU - Yang, Lu
AU  - Yang L
AD  - Department of Urology, Institute of Urology, West China Hospital, Sichuan 
      University, Chengdu, China.
FAU - Wei, Qiang
AU  - Wei Q
AD  - Department of Urology, Institute of Urology, West China Hospital, Sichuan 
      University, Chengdu, China.
LA  - eng
PT  - Case Reports
PL  - China
TA  - Transl Androl Urol
JT  - Translational andrology and urology
JID - 101581119
PMC - PMC7947464
OTO - NOTNLM
OT  - Primary scrotal lipoma
OT  - case report
OT  - diagnosis
OT  - treatment
COIS- Conflicts of Interest: All authors have completed the ICMJE uniform disclosure 
      form (available at http://dx.doi.org/10.21037/tau-20-1073). The authors have no 
      conflicts of interest to declare.
EDAT- 2021/03/16 06:00
MHDA- 2021/03/16 06:01
PMCR- 2021/02/01
CRDT- 2021/03/15 07:07
PHST- 2021/03/15 07:07 [entrez]
PHST- 2021/03/16 06:00 [pubmed]
PHST- 2021/03/16 06:01 [medline]
PHST- 2021/02/01 00:00 [pmc-release]
AID - tau-10-02-983 [pii]
AID - 10.21037/tau-20-1073 [doi]
PST - ppublish
SO  - Transl Androl Urol. 2021 Feb;10(2):983-990. doi: 10.21037/tau-20-1073.